New hearing implant sentio under study: could it help the deaf hear?
NCT ID NCT07161154
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will observe 100 adults who receive the Sentio bone conduction hearing system as part of their normal care. The device is implanted under the skin and sends sound vibrations through the skull to the inner ear. Researchers will track how often the device is used successfully, any complications, and whether hearing improves. The goal is to see how well the system works in real-world practice for people with various types of hearing loss.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Sentio transcutaneous bone conduction hearing system (device)
- What this could lead to
- If successful, this study could confirm that the Sentio device is a safe and effective option for people with certain types of hearing loss.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be less definitive. It is also small (100 participants) and not yet recruiting, so findings are preliminary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2025
An estimate. Start dates often move.
- Expected to finish
-
Dec 2035
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients receiving the Sentio system in clinical practice
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Subject who is scheduled for or have undergone Sentio implantation in clinical practice. * Subject who has consented to participation or are covered by consent waiver. Exclusion Criteria: * Subjects enrolled in other clinical investigations leading to their Sentio implantation and subsequent follow-up deviating substantially from clinical practice
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hearing aid are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartphone app replace the clinic for hearing aid tuning?
- 30 years of cochlear implant data could reshape hearing care in china
- Can visual cues unlock sentence building in children with language delays?
- Can a new hearing aid strategy cut through the noise?
- Can a custom sound map unlock better hearing for cochlear implant users?
- Can a new bone conduction implant restore hearing for the long haul?